nagilactone c has been researched along with Alveolitis, Fibrosing in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Feng, ZL; Li, A; Lin, LG; Liu, LJ; Lu, JJ; Xiao, X; Zhang, LL | 1 |
1 other study(ies) available for nagilactone c and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
Topics: Animals; Biomarkers; Bleomycin; Cells, Cultured; Diterpenes; Female; Fibroblasts; Humans; Lung; Mice; Mice, Inbred C57BL; Myofibroblasts; Pulmonary Fibrosis; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Smad2 Protein; Terpenes; Transforming Growth Factor beta1 | 2020 |